Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

I-MIBG imaging for detection of anthracycline-induced cardiomyopathy

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Myocardial perfusion assessed with cardiac computed tomography in women without coronary heart disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cardiometabolic effects of antidiabetic drugs in non-alcoholic fatty liver disease

    Research output: Contribution to journalReviewResearchpeer-review

  3. Validation of non-invasive haemodynamic methods in patients with liver disease: the Finometer and the Task Force Monitor

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. (18) F-FDG PET/CT for planning external beam radiotherapy alters therapy in 11% of 581 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Association between Type D personality and outcomes in patients with non-ischemic heart failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Near-infrared fluorescence imaging improves the nodal yield in neck dissection in oral cavity cancer - A randomized study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Duration of Heart Failure and Effect of Defibrillator Implantation in Patients With Nonischemic Systolic Heart Failure

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Due to improvements in early detection and treatment of malignant disease, the population of cancer survivors is constantly expanding. Cancer survivors are faced with chemotherapy-related long-term side effects, including irreversible cardiac injury with risk of heart failure (HF). Numerous antineoplastic regimens are associated with risk of cardiac side effects, but anthracyclines in particular carry a severe risk of cardiotoxicity. Currently, serial echocardiographic evaluation of resting left ventricular ejection fraction (LVEF) is the gold standard for monitoring anthracycline-induced cardiac side effects from chemotherapy. LVEF measurements are, however, limited by their low sensitivity. A normal LVEF does not exclude cardiotoxicity and declines in LVEF are usually not observed before the occurrence of irreversible cardiomyopathy. Hence, a clinically applicable high-sensitivity diagnostic tool for early detection of chemotherapy-related cardiotoxicity is still lacking and alternative non-invasive imaging modalities are therefore being investigated.123I-MIBG is a noradrenaline (NA) analogue used for evaluation of cardiac adrenergic function, including assessment of HF prognosis and evaluation of HF treatment response. However, the role of123I-MIBG for monitoring chemotherapy-related cardiotoxicity is still unclear. Here, we review the value of123I-MIBG imaging for early detection and prevention of anthracycline-induced cardiomyopathy.

Original languageEnglish
JournalClinical Physiology and Functional Imaging
Volume38
Issue number2
Pages (from-to)176-185
Number of pages10
ISSN1475-0961
DOIs
Publication statusPublished - Mar 2018

    Research areas

  • Journal Article, Review

ID: 52702853